BioSyent Inc. (RX.V)
CAD 10.36
(3.6%)
CAD 10.36
(3.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.05 Million CAD | 1.34% |
| 2022 | 7.95 Million CAD | -12.08% |
| 2021 | 8.92 Million CAD | 52.0% |
| 2020 | 5.84 Million CAD | -3.72% |
| 2019 | 6.19 Million CAD | -6.51% |
| 2018 | 7.73 Million CAD | 5.24% |
| 2017 | 7.03 Million CAD | 5.55% |
| 2016 | 5.9 Million CAD | 15.26% |
| 2015 | 5.11 Million CAD | 19.04% |
| 2014 | 4.29 Million CAD | 75.19% |
| 2013 | 2.45 Million CAD | 74.13% |
| 2012 | 1.42 Million CAD | 125.06% |
| 2011 | 430.92 Thousand CAD | 884.47% |
| 2010 | 126.02 Thousand CAD | 123.63% |
| 2009 | -247.33 Thousand CAD | 1.78% |
| 2008 | -278.17 Thousand CAD | -75.16% |
| 2007 | -156.48 Thousand CAD | -143.31% |
| 2006 | 361.27 Thousand CAD | 482.2% |
| 2005 | -113.34 Thousand CAD | 68.91% |
| 2004 | -304.02 Thousand CAD | 6.2% |
| 2003 | -324.12 Thousand CAD | -64.33% |
| 2002 | -197.44 Thousand CAD | 11.05% |
| 2001 | -221.74 Thousand CAD | -79.46% |
| 2000 | -123.56 Thousand CAD | 38.22% |
| 1999 | -200.69 Thousand CAD | 77.78% |
| 1998 | -1 Million CAD | -80.0% |
| 1997 | -400 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.07 Million CAD | -9.86% |
| 2024 Q1 | 2.2 Million CAD | 27.33% |
| 2023 Q4 | 1.63 Million CAD | -48.48% |
| 2023 Q1 | 1.77 Million CAD | -1.84% |
| 2023 Q3 | 3.17 Million CAD | 44.1% |
| 2023 FY | - CAD | 1.34% |
| 2023 Q2 | 2.2 Million CAD | 24.1% |
| 2022 Q2 | 1.72 Million CAD | -24.66% |
| 2022 Q1 | 2.29 Million CAD | -14.54% |
| 2022 Q3 | 2.05 Million CAD | 18.82% |
| 2022 Q4 | 1.8 Million CAD | -12.05% |
| 2022 FY | - CAD | -12.08% |
| 2021 Q2 | 1.58 Million CAD | -36.11% |
| 2021 Q3 | 2.22 Million CAD | 40.6% |
| 2021 Q4 | 2.68 Million CAD | 20.71% |
| 2021 Q1 | 2.47 Million CAD | 98.44% |
| 2021 FY | - CAD | 52.0% |
| 2020 FY | - CAD | -3.72% |
| 2020 Q3 | 1.44 Million CAD | 29.82% |
| 2020 Q1 | 2.08 Million CAD | 18.11% |
| 2020 Q4 | 1.24 Million CAD | -13.83% |
| 2020 Q2 | 1.11 Million CAD | -46.59% |
| 2019 Q2 | 860.25 Thousand CAD | -28.38% |
| 2019 FY | - CAD | -6.51% |
| 2019 Q3 | 2.08 Million CAD | 142.3% |
| 2019 Q4 | 1.76 Million CAD | -15.18% |
| 2019 Q1 | 1.2 Million CAD | -40.5% |
| 2018 Q4 | 2.01 Million CAD | 46.1% |
| 2018 Q2 | 2.07 Million CAD | 93.4% |
| 2018 FY | - CAD | 5.24% |
| 2018 Q1 | 1.07 Million CAD | -33.63% |
| 2018 Q3 | 1.38 Million CAD | -33.53% |
| 2017 Q3 | 1.73 Million CAD | -14.23% |
| 2017 FY | - CAD | 5.55% |
| 2017 Q4 | 1.61 Million CAD | -6.68% |
| 2017 Q2 | 2.02 Million CAD | 69.83% |
| 2017 Q1 | 1.19 Million CAD | -25.12% |
| 2016 Q2 | 1.39 Million CAD | 10.82% |
| 2016 Q4 | 1.59 Million CAD | -3.38% |
| 2016 Q1 | 1.26 Million CAD | 25.2% |
| 2016 Q3 | 1.64 Million CAD | 17.65% |
| 2016 FY | - CAD | 15.26% |
| 2015 Q1 | 1.31 Million CAD | 24.39% |
| 2015 Q2 | 1.17 Million CAD | -10.52% |
| 2015 FY | - CAD | 19.04% |
| 2015 Q4 | 1 Million CAD | -37.73% |
| 2015 Q3 | 1.61 Million CAD | 37.72% |
| 2014 Q4 | 1.05 Million CAD | -21.5% |
| 2014 Q3 | 1.34 Million CAD | 11.14% |
| 2014 Q2 | 1.21 Million CAD | 76.47% |
| 2014 Q1 | 686.28 Thousand CAD | 11.49% |
| 2014 FY | - CAD | 75.19% |
| 2013 Q1 | 484.2 Thousand CAD | 35.67% |
| 2013 Q2 | 542.48 Thousand CAD | 12.04% |
| 2013 Q3 | 812.15 Thousand CAD | 49.71% |
| 2013 Q4 | 615.56 Thousand CAD | -24.21% |
| 2013 FY | - CAD | 74.13% |
| 2012 Q4 | 356.91 Thousand CAD | -17.77% |
| 2012 Q3 | 434.05 Thousand CAD | 27.38% |
| 2012 Q2 | 340.76 Thousand CAD | 23.77% |
| 2012 Q1 | 275.32 Thousand CAD | 68.06% |
| 2012 FY | - CAD | 125.06% |
| 2011 Q1 | 5400.00 CAD | -93.45% |
| 2011 FY | - CAD | 884.47% |
| 2011 Q4 | 163.82 Thousand CAD | -32.57% |
| 2011 Q3 | 242.96 Thousand CAD | 70.93% |
| 2011 Q2 | 142.13 Thousand CAD | 2532.15% |
| 2010 Q1 | -47.79 Thousand CAD | 71.33% |
| 2010 Q4 | 82.46 Thousand CAD | -37.36% |
| 2010 Q3 | 131.64 Thousand CAD | 228.71% |
| 2010 Q2 | -102.28 Thousand CAD | -114.03% |
| 2010 FY | - CAD | 123.63% |
| 2009 Q1 | -189.8 Thousand CAD | -29.66% |
| 2009 Q4 | -166.68 Thousand CAD | -213.54% |
| 2009 Q2 | -58.52 Thousand CAD | 69.17% |
| 2009 Q3 | 146.8 Thousand CAD | 350.83% |
| 2009 FY | - CAD | 1.78% |
| 2008 FY | - CAD | -75.16% |
| 2008 Q4 | -146.38 Thousand CAD | -404.75% |
| 2008 Q3 | 48.03 Thousand CAD | 150.13% |
| 2008 Q2 | -95.81 Thousand CAD | -19.9% |
| 2008 Q1 | -79.91 Thousand CAD | 51.37% |
| 2007 Q2 | -155.45 Thousand CAD | -311.19% |
| 2007 FY | - CAD | -143.31% |
| 2007 Q1 | -37.8 Thousand CAD | -161.31% |
| 2007 Q4 | -164.35 Thousand CAD | -181.71% |
| 2007 Q3 | 201.13 Thousand CAD | 229.38% |
| 2006 Q1 | 40.89 Thousand CAD | 105.98% |
| 2006 FY | - CAD | 482.2% |
| 2006 Q4 | 61.66 Thousand CAD | -79.76% |
| 2006 Q3 | 304.71 Thousand CAD | 699.28% |
| 2006 Q2 | -50.84 Thousand CAD | -224.34% |
| 2005 Q4 | -684.21 Thousand CAD | -1822.73% |
| 2005 Q3 | 39.71 Thousand CAD | 411.95% |
| 2005 FY | - CAD | 68.91% |
| 2005 Q1 | 538.7 Thousand CAD | 477.34% |
| 2005 Q2 | -12.73 Thousand CAD | -102.36% |
| 2004 Q4 | -142.76 Thousand CAD | -386.62% |
| 2004 Q1 | -65.1 Thousand CAD | 73.76% |
| 2004 Q2 | -66.81 Thousand CAD | -2.63% |
| 2004 FY | - CAD | 6.2% |
| 2004 Q3 | -29.33 Thousand CAD | 56.09% |
| 2003 Q1 | -136.65 Thousand CAD | 5.63% |
| 2003 FY | - CAD | -64.33% |
| 2003 Q4 | -248.17 Thousand CAD | -504.23% |
| 2003 Q3 | 61.39 Thousand CAD | 624.06% |
| 2003 Q2 | -26.18 Thousand CAD | 91.43% |
| 2002 Q1 | -111.15 Thousand CAD | 37.64% |
| 2002 Q2 | -62.94 Thousand CAD | 43.37% |
| 2002 Q4 | -144.8 Thousand CAD | -209.73% |
| 2002 FY | - CAD | 11.05% |
| 2002 Q3 | 131.96 Thousand CAD | 309.64% |
| 2001 Q3 | 116 Thousand CAD | 253.85% |
| 2001 Q1 | -84.09 Thousand CAD | -170.05% |
| 2001 FY | - CAD | -79.46% |
| 2001 Q4 | -178.24 Thousand CAD | -253.65% |
| 2001 Q2 | -75.4 Thousand CAD | 10.34% |
| 2000 Q4 | -31.14 Thousand CAD | -135.25% |
| 2000 Q3 | 88.34 Thousand CAD | 188.35% |
| 2000 Q2 | -100 Thousand CAD | 0.0% |
| 2000 Q1 | -100 Thousand CAD | 0.0% |
| 2000 FY | - CAD | 38.22% |
| 1999 Q3 | 200 Thousand CAD | 300.0% |
| 1999 Q4 | -100 Thousand CAD | -150.0% |
| 1999 Q1 | -200 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 77.78% |
| 1999 Q2 | -100 Thousand CAD | 50.0% |
| 1998 Q1 | -100 Thousand CAD | 0.0% |
| 1998 Q4 | -200 Thousand CAD | -100.0% |
| 1998 FY | - CAD | -80.0% |
| 1998 Q3 | -100 Thousand CAD | 75.0% |
| 1998 Q2 | -400 Thousand CAD | -300.0% |
| 1997 Q4 | - CAD | 100.0% |
| 1997 Q3 | -300 Thousand CAD | 0.0% |
| 1997 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.68 Million CAD | 437.797% |
| CanadaBis Capital Inc. | 5.67 Million CAD | -59.524% |
| Decibel Cannabis Company Inc. | 5.67 Million CAD | -59.493% |
| Delivra Health Brands Inc. | 2.35 Million CAD | -284.775% |
| Entourage Health Corp. | -21.39 Million CAD | 142.331% |
| Lifeist Wellness Inc. | -12.76 Million CAD | 170.93% |
| Cannara Biotech Inc. | 17.18 Million CAD | 47.3% |
| Medicure Inc. | 1.27 Million CAD | -611.517% |
| PharmaCielo Ltd. | -12.01 Million CAD | 175.363% |
| Rubicon Organics Inc. | 1.94 Million CAD | -364.969% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 841.848% |